Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,341 | 101,536 | 110,901 | 53,726 | 94,569 |
| Marketable Securities | 1,176,965 | 926,353 | 981,890 | 1,143,134 | 1,180,055 |
| Receivables | 5,683 | 592 | N/A | N/A | N/A |
| Inventories | 3,064 | 2,022 | N/A | N/A | N/A |
| TOTAL | $1,322,414 | $1,048,342 | $1,121,275 | $1,217,264 | $1,291,055 |
| Non-Current Assets | |||||
| PPE Net | 13,497 | 14,296 | 14,377 | 14,670 | 12,628 |
| Other Non-Current Assets | 65,412 | 63,619 | 60,379 | 57,640 | 57,644 |
| TOTAL | $78,909 | $77,915 | $74,756 | $72,310 | $70,272 |
| Total Assets | $1,401,323 | $1,126,257 | $1,196,031 | $1,289,574 | $1,361,327 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,487 | 41,770 | 33,674 | 38,086 | 31,616 |
| Accrued Expenses | 25,792 | 35,578 | 32,398 | 21,796 | 16,606 |
| TOTAL | $71,086 | $85,072 | $74,155 | $68,396 | $57,311 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,271 | 1,235 | 1,642 | 1,904 | 2,206 |
| Other Non-Current Liabilities | 46,245 | 45,292 | 45,597 | 45,660 | 45,703 |
| TOTAL | $49,591 | $49,102 | $49,707 | $49,652 | $50,016 |
| Total Liabilities | $120,677 | $134,174 | $123,862 | $118,048 | $107,327 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,440 | 104,705 | 94,892 | 94,176 | 93,680 |
| Common Shares | 2,828,204 | 2,407,757 | 2,364,699 | 2,334,538 | 2,300,882 |
| Retained earnings | -1,545,272 | -1,417,427 | -1,294,612 | -1,164,521 | -1,048,884 |
| Other shareholders' equity | -1,286 | 1,753 | 2,082 | 1,509 | 2,002 |
| TOTAL | $1,280,646 | $992,083 | $1,072,169 | $1,171,526 | $1,254,000 |
| Total Liabilities And Equity | $1,401,323 | $1,126,257 | $1,196,031 | $1,289,574 | $1,361,327 |